BridgeMD

Sign in

Tuberculosis clinical trials

Explore recruiting tuberculosis clinical trials.

Recruiting tuberculosis studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tuberculosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Low Intervention, Open, Multicentric, Phase IV Exploratory Clinical Trial to evaluate new biomarkers for the diagnosis and treatment monitoring of tuberculosis

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Safety and immune responses after vaccination with two investigational RNA-based vaccines against tuberculosis in healthy volunteers

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Trial to Determine if Quabodepistat is Processed Differently in Adults with Reduced Liver Function Compared to Adults with Normal Liver Function

Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

A study to investigate the pharmacokinetics of a combined oral contraceptive when given alone and in combination with GSK3036656 in female participants of non-childbearing potential aged 18 to 65 years of age

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Evaluation of the early bactericidal activity of tedizolid and linezolide against Mycobacterium tuberculosis (TEDITUB)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BASED ON HIGH DOSE RIFAMPICIN, HIGH DOSE MOXIFLOXACIN AND LINEZOLID IN PATIENTS WITH BACILLIFEROUS PULMONARY TUBERCULOSIS (RML-TB).

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Tuberculosis trials by city

Tuberculosis in Toronto Tuberculosis in Vancouver Tuberculosis in Montreal Tuberculosis in Calgary Tuberculosis in Edmonton Tuberculosis in Ottawa Tuberculosis in Winnipeg Tuberculosis in Quebec City Tuberculosis in Hamilton Tuberculosis in Kitchener Tuberculosis in London Tuberculosis in Halifax Tuberculosis in New York Tuberculosis in Los Angeles Tuberculosis in Chicago Tuberculosis in Houston